T1	Observation 47 62	body mass index
T2	Observation-Name 47 62	body mass index
E1	Observation:T1 Name:T2
A1	Observation-Type-Value T2 vital
T3	Condition 94 109	menstrual cycle
T4	Condition-Name 94 109	menstrual cycle
E3	Condition:T3 Name:T4 Polarity:T9
T5	Observation 64 67	BMI
T6	Observation-Name 64 67	BMI
E5	Observation:T5 Name:T6 Eq-Comparison:E37
A2	Observation-Type-Value T6 vital
T10	Condition 618 639	recurrent miscarriage
T11	Condition-Name 618 639	recurrent miscarriage
E10	Condition:T10 Name:T11 Temporality:E34
T12	Condition 536 543	disease
T13	Condition-Name 536 543	disease
E12	Condition:T12 Name:T13
T14	Condition 315 332	metabolic disease
T15	Condition-Name 315 332	metabolic disease
E14	Condition:T14 Name:T15
T16	Condition 360 376	genetic diseases
T17	Condition-Name 360 376	genetic diseases
E16	Condition:T16 Name:T17
T18	Condition 394 407	heart disease
T19	Condition-Name 394 407	heart disease
E18	Condition:T18 Name:T19
T20	Condition 425 438	heart failure
T21	Condition-Name 425 438	heart failure
E20	Condition:T20 Name:T21
T22	Condition 468 481	liver failure
T23	Condition-Name 468 481	liver failure
E22	Condition:T22 Name:T23
T24	Condition 574 587	endometriosis
T25	Condition-Name 574 587	endometriosis
E24	Condition:T24 Name:T25 Stage:E31
T26	Procedure 672 689	stimulation cycle
T27	Procedure-Name 672 689	stimulation cycle
E26	Procedure:T26 Name:T27 Temporality:E40
T28	Condition 483 492	hepatitis
T29	Condition-Name 483 492	hepatitis
E28	Condition:T28 Name:T29
T30	Condition 296 304	diabetes
T31	Condition-Name 296 304	diabetes
E30	Condition:T30 Name:T31
T32	Condition 653 657	OHSS
T33	Condition-Name 653 657	OHSS
E32	Condition:T32 Name:T33 Severity:T92
T34	Eq-Operator 158 159	≥
A3	Eq-Operator-Value T34 GTEQ
T36	Eq-Temporal-Unit 35 40	years
A5	Eq-Temporal-Unit-Value T36 year
T37	Eq-Temporal-Unit 119 123	days
A6	Eq-Temporal-Unit-Value T37 day
T38	Eq-Unit 74 76	kg
T39	Age 25 28	age
E33	Age:T39 Eq-Comparison:E36
T41	Eq-Operator 31 32	-
A7	Eq-Operator-Value T41 BETWEEN
T42	Eq-Operator 71 72	-
A8	Eq-Operator-Value T42 BETWEEN
T43	Eq-Operator 115 116	-
A9	Eq-Operator-Value T43 BETWEEN
T44	Eq-Operator 249 250	-
A10	Eq-Operator-Value T44 BETWEEN
T45	Eq-Value 29 31	20
T46	Eq-Value 32 34	34
T47	Eq-Value 69 71	18
T48	Eq-Value 72 74	29
T49	Eq-Value 113 115	26
T50	Eq-Value 116 118	35
T51	Eq-Value 159 162	2.3
T52	Eq-Value 250 252	12
T53	Eq-Comparison 158 168	≥2.3 ng/ml
E35	Eq-Comparison:T53 Operator:T34 Value:T51 Unit:T40 Per:T59
T54	Eq-Comparison 29 40	20-34 years
E36	Eq-Comparison:T54 Operator:T41 Value:T45 Value2:T46 Temporal-Unit:T36
T55	Eq-Comparison 69 79	18-29kg/m2
E37	Eq-Comparison:T55 Operator:T42 Value:T47 Per:T8 Unit:T38 Value2:T48
T56	Eq-Comparison 113 123	26-35 days
E38	Eq-Comparison:T56 Operator:T43 Value:T49 Temporal-Unit:T37 Value2:T50
T57	Eq-Comparison 248 257	1-12 IU/l
E39	Eq-Comparison:T57 Operator:T44 Value:T52 Value2:T64 Unit:T65 Per:T66
R1	Abbrev-Of Arg1:E5 Arg2:E1	
T8	Eq-Unit 77 79	m2
T9	Polarity 86 93	regular
A11	Polarity-Value T9 normal
T7	Observation 130 133	AMH
E2	Observation:T7 Name:T58 Eq-Comparison:E35
T58	Observation-Name 130 133	AMH
A12	Observation-Type-Value T58 lab
T40	Eq-Unit 163 165	ng
T59	Eq-Unit 166 168	ml
T35	Observation 199 225	serum concentration of FSH
E4	Observation:T35 Name:T60
T60	Observation-Name 199 225	serum concentration of FSH
A4	Observation-Type-Value T60 lab
T61	Modifier 175 198	early follicular- phase
E6	Modifier:T61 Modifies:T60
T62	Eq-Comparison 226 246	within normal limits
E7	Eq-Comparison:T62 Unit:T63
T63	Eq-Unit 226 246	within normal limits
A13	Eq-Unit-Value T63 ref-range-normal
T64	Eq-Value 248 249	1
T65	Eq-Unit 253 255	IU
T66	Eq-Unit 256 257	l
R2	Equivalent-To Arg1:E39 Arg2:E7	
T67	Life-Stage-And-Gender 285 290	women
A14	Life-Stage-And-Gender-Type T67 female
T68	And 291 295	with
E8	And:T68 Arg:T67 Arg2:E30
T69	Or 305 308	and
E9	Or:T69 Arg:E30 Arg2:E14
T70	Other 309 314	other
E11	Other:T70 Is-Other:E14
T71	Life-Stage-And-Gender 338 343	women
A15	Life-Stage-And-Gender-Type T71 female
T72	Modifier 349 359	hereditary
E13	Modifier:T72 Modifies:T17
T73	And 344 348	with
E15	And:T73 Arg:T71 Arg2:E16
T74	Life-Stage-And-Gender 383 388	women
A16	Life-Stage-And-Gender-Type T74 female
T75	And 389 393	with
E17	And:T75 Arg:T74 Arg2:E18
T76	Condition 409 424	QT prolongation
E19	Condition:T76 Name:T77
T77	Condition-Name 409 424	QT prolongation
T78	Condition 453 466	liver enzymes
E21	Condition:T78 Name:T79 Polarity:T80
T79	Condition-Name 453 466	liver enzymes
T80	Polarity 444 452	elevated
A17	Polarity-Value T80 high
T81	Life-Stage-And-Gender 498 503	women
A18	Life-Stage-And-Gender-Type T81 female
T82	Modifier 525 535	autoimmune
E23	Modifier:T82 Modifies:T13
T83	Modifier 509 521	inflammatory
E25	Modifier:T83 Modifies:T13
T84	Or 522 524	or
E27	Or:T84 Arg:E25 Arg2:E23
T85	And 504 508	with
E29	And:T85 Arg:T81 Arg2:E12
T86	Eq-Comparison 588 600	stage III/IV
E31	Eq-Comparison:T86 Unit:T87 Value:T88 Value2:T89
T87	Eq-Unit 588 593	stage
T88	Eq-Value 594 597	III
T89	Eq-Value 598 600	IV
T90	Eq-Comparison 607 614	history
E34	Eq-Comparison:T90 Temporal-Period:T91
T91	Eq-Temporal-Period 607 614	history
A19	Eq-Temporal-Period-Value T91 past
T92	Severity 646 652	severe
A20	Severity-Value T92 severe
T93	Eq-Comparison 663 671	previous
E40	Eq-Comparison:T93 Temporal-Period:T94
T94	Eq-Temporal-Period 663 671	previous
A21	Eq-Temporal-Period-Value T94 past
T95	Temporal-Connection 658 660	in
E41	Temporal-Connection:T95 Arg:E32 Arg2:E40
A22	Temporal-Connection-Type-Value E41 during
T96	Contraindication 697 713	contraindication
E42	Contraindication:T96 Contraindicates:E43
T97	Drug 729 743	gonadotrophins
E43	Drug:T97 Name:T98
T98	Drug-Name 729 743	gonadotrophins
T99	Or 690 692	or
E44	Or:T99 Arg:E26 Arg2:E42
T100	Condition 558 567	karyotype
E45	Condition:T100 Name:T101 Polarity:T102
T101	Condition-Name 558 567	karyotype
T102	Polarity 549 557	abnormal
A23	Polarity-Value T102 abnormal
